Abingdon Health Plc reported revenue results for the six months ended December 31, 2023. For the period, the company reported revenues more than doubled (+118%) to £2.4 million (first of 2022/3 £1.1 million). The growth has been driven by the company's contract service customer base across lateral flow research & development, technical transfer, manufacturing, analytical and regulatory services.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.49 GBX | +4.90% | -0.10% | -4.64% |
Mar. 25 | Peel Hunt's RetailBook raises GBP2.5 million | AN |
Mar. 25 | Abingdon Health Completes Design Freeze for STD Self-Tests | MT |
1st Jan change | Capi. | |
---|---|---|
-4.64% | 38.65M | |
+0.89% | 12.95B | |
-7.57% | 7.84B | |
+1.74% | 5.5B | |
+0.93% | 4.61B | |
+6.84% | 4.61B | |
-48.50% | 3.4B | |
+9.21% | 2.66B | |
-14.59% | 2.08B | |
+3.19% | 1.79B |
- Stock Market
- Equities
- ABDX Stock
- News Abingdon Health Plc
- Abingdon Health Plc Reports Revenue Results for the Six Months Ended December 31, 2023